Phase I-II Study Evaluating Combined Treatment of Cetuximab and Trastuzumab in Metastatic Pancreatic Cancer Patients Progressing After Gemcitabine Based Chemotherapy.
Phase of Trial: Phase I/II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Trastuzumab (Primary) ; Cetuximab
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms THERAPY
- 09 Jul 2012 Last checked against European Clinical Trials Database record.
- 24 Jun 2009 New trial record